1 |
Avadhani A, Cardinale M, Akintade B. COVID-19 pneumonia: What APRNs should know. Nurse Pract 2021;46:22-8. [PMID: 34138809 DOI: 10.1097/01.NPR.0000753828.91626.a1] [Reference Citation Analysis]
|
2 |
Liskova A, Koklesova L, Samec M, Abdellatif B, Zhai K, Siddiqui M, Šudomová M, Hassan STS, Kudela E, Biringer K, Giordano FA, Büsselberg D, Golubnitschaja O, Kubatka P. Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks. EPMA J 2021;:1-23. [PMID: 34367380 DOI: 10.1007/s13167-021-00249-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Calkovska A, Kolomaznik M, Calkovsky V. Alveolar type II cells and pulmonary surfactant in COVID-19 era. Physiol Res 2021;70:S195-208. [PMID: 34913352 DOI: 10.33549/physiolres.934763] [Reference Citation Analysis]
|
4 |
Xue M, Zhang T, Cheng ZJ, Guo B, Zeng Y, Lin R, Zheng P, Liu M, Hu F, Li F, Zhang W, Li L, Zhao Q, Sun B, Tang X. Effect of a Functional Phospholipid Metabolome-Protein Association Pathway on the Mechanism of COVID-19 Disease Progression. Int J Biol Sci 2022;18:4618-28. [PMID: 35874944 DOI: 10.7150/ijbs.72450] [Reference Citation Analysis]
|
5 |
Middleton S, Dimbath E, Pant A, George S, Maddipati V, Peach MS, Yang K, Ju AW, Vahdati A. Towards a multi-scale computer modeling workflow for simulation of pulmonary ventilation in advanced COVID-19. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.105513] [Reference Citation Analysis]
|